Genomic Assessment of Patients With Severe Radiation Reactions

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03287349

Enrollment

Registered

2017-09-19

Start date

2017-05-10

Completion date

2023-01-04

Last updated

2024-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation; Reaction

Brief summary

Determine an underlying etiology behind unexpectedly severe reactions to radiation by blood draw.

Interventions

OTHERBlood draw

Two 12.5 mL blood draws

OTHERPhotograph

Photograph of severe reaction, will be anonymized

DIAGNOSTIC_TESTAutoimmune testing

Autoimmune testing in patients without prior testing

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Weigh at least 110 pounds * Healthy

Exclusion criteria

\- Pregnant

Design outcomes

Primary

Measure	Time frame	Description
Whole exome sequencing	baseline	Investigate genes potentially responsible for severe radiation reactions by getting blood draws.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026